Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Kidney tissue replacement by organ transplantation" refers to the **surgical procedure** in which a healthy kidney from a living or deceased donor is transplanted into a patient with end-stage renal disease or irreversible kidney failure. The transplanted kidney takes over the filtration and regulatory functions lost by the patient's own kidneys. This process requires lifelong use of immunosuppressive drugs to prevent immune-mediated rejection of the new organ, which introduces risks such as infection and malignancy. The term does not refer to a specific molecule, receptor, enzyme, transporter, or other canonical therapeutic target but rather describes an entire medical intervention involving complex surgical and pharmacological management.[1][3][5]
Suppression of immune response to prevent organ rejection
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney tissue replacement by organ transplantation.